Adequate statistical power in clinical trials is associated with the combination of a male first author and a female last author
Clinical trials have a vital role in ensuring the safety and efficacy of new treatments and interventions in medicine. A key characteristic of a clinical trial is its statistical power. Here we investigate whether the statistical power of a trial is related to the gender of first and last authors on...
Main Authors: | Willem M Otte, Joeri K Tijdink, Paul L Weerheim, Herm J Lamberink, Christiaan H Vinkers |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2018-06-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/34412 |
Similar Items
-
Applicable or non-applicable: investigations of clinical heterogeneity in systematic reviews
by: Laura E. Chess, et al.
Published: (2016-02-01) -
Assessing the treatment effect from multiple trials in idiopathic pulmonary fibrosis
by: L. Richeldi
Published: (2012-06-01) -
The Impact of Drug Trials With Financial Conflict of Interests on the Meta-analyses: A Meta-epidemiological Study
by: Na Zhang, et al.
Published: (2022-10-01) -
From meta‐analysis to Cochrane reviews
by: Nicole Ebner, et al.
Published: (2018-06-01) -
Study results from journals with a higher impact factor are closer to “truth”: a meta-epidemiological study
by: Andreas Heidenreich, et al.
Published: (2023-01-01)